EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 374 filers reported holding EXELIXIS INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,466 | -51.5% | 1,257 | -57.5% | 0.00% | – |
Q2 2023 | $56,585 | +4.8% | 2,961 | +6.5% | 0.00% | – |
Q1 2023 | $53,979 | +25.0% | 2,781 | +3.3% | 0.00% | – |
Q4 2022 | $43,196 | +8.0% | 2,693 | +7.4% | 0.00% | – |
Q3 2022 | $40,000 | +66.7% | 2,508 | +121.2% | 0.00% | – |
Q2 2022 | $24,000 | -4.0% | 1,134 | +5.7% | 0.00% | – |
Q1 2022 | $25,000 | +13.6% | 1,073 | -11.2% | 0.00% | – |
Q4 2021 | $22,000 | +1000.0% | 1,209 | +1109.0% | 0.00% | – |
Q3 2021 | $2,000 | -83.3% | 100 | -84.0% | 0.00% | – |
Q2 2021 | $12,000 | -7.7% | 625 | +6.8% | 0.00% | – |
Q1 2021 | $13,000 | -7.1% | 585 | -12.4% | 0.00% | – |
Q4 2020 | $14,000 | -92.0% | 668 | -90.7% | 0.00% | – |
Q3 2020 | $175,000 | -20.1% | 7,151 | -22.4% | 0.00% | -100.0% |
Q2 2020 | $219,000 | +34.4% | 9,214 | -2.2% | 0.00% | 0.0% |
Q1 2020 | $163,000 | -13.3% | 9,424 | -11.9% | 0.00% | 0.0% |
Q4 2019 | $188,000 | -5.5% | 10,698 | -4.8% | 0.00% | 0.0% |
Q3 2019 | $199,000 | -12.7% | 11,242 | +5.2% | 0.00% | 0.0% |
Q2 2019 | $228,000 | -23.2% | 10,690 | -14.3% | 0.00% | 0.0% |
Q1 2019 | $297,000 | +21.7% | 12,481 | +0.6% | 0.00% | 0.0% |
Q4 2018 | $244,000 | +8.4% | 12,403 | -2.6% | 0.00% | 0.0% |
Q3 2018 | $225,000 | +136.8% | 12,735 | +188.5% | 0.00% | 0.0% |
Q2 2018 | $95,000 | +90.0% | 4,414 | +96.9% | 0.00% | – |
Q1 2018 | $50,000 | -30.6% | 2,242 | -5.2% | 0.00% | – |
Q4 2017 | $72,000 | – | 2,366 | +11730.0% | 0.00% | – |
Q2 2017 | $0 | -100.0% | 20 | -55.6% | 0.00% | – |
Q4 2016 | $1,000 | -75.0% | 45 | -91.0% | 0.00% | – |
Q2 2016 | $4,000 | -66.7% | 500 | -82.8% | 0.00% | – |
Q1 2016 | $12,000 | +9.1% | 2,913 | 0.0% | 0.00% | – |
Q2 2015 | $11,000 | +22.2% | 2,913 | -14.6% | 0.00% | – |
Q1 2015 | $9,000 | +28.6% | 3,413 | -33.5% | 0.00% | – |
Q4 2014 | $7,000 | -46.2% | 5,131 | -38.4% | 0.00% | – |
Q3 2014 | $13,000 | -53.6% | 8,324 | 0.0% | 0.00% | -100.0% |
Q2 2014 | $28,000 | +16.7% | 8,324 | +21.4% | 0.00% | 0.0% |
Q1 2014 | $24,000 | -20.0% | 6,854 | +41.4% | 0.00% | 0.0% |
Q4 2013 | $30,000 | +7.1% | 4,846 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $28,000 | +27.3% | 4,846 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $22,000 | – | 4,846 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |